Work

Perspective on this Article from A Randomized, Double-Blind, Placebo-Controlled Phase 3 Skin Cancer Prevention Study of α-Difluoromethylornithine in Subjects with Previous History of Skin Cancer

Year: 2023

Type: other

Abstract: Perspective on this Article from A Randomized, Double-Blind, Placebo-Controlled Phase 3 Skin Cancer Prevention Study of α-Difluoromethylornithine in Subjects with Previous History of Skin Cancer

DOI: 10.1158/1940-6207.22525221.v1

Authors: Howard H. Bailey, KyungMann Kim, Ajit K. Verma, Karen Sielaff, Paul O. Larson, Stephen Snow, Theresa Lenaghan, Jaye L. Viner, Jeff Douglas, Nancy E. Dreckschmidt, Mary Hamielec, Marcy Pomplun, Harry H. Sharata, David Puchalsky, Eric R. Berg, Thomas C. Havighurst, Paul P. Carbone

Language: English

Topic: Nonmelanoma Skin Cancer Studies

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362485342

Cites:

Cited by:

Related to: 10